SFM
Sphera Funds Management Portfolio holdings
AUM
$479M
1-Year Est. Return
66.44%
This Fund
S&P 500
1 Year Est. Return
+66.44%
AUM
$479M
AUM Growth
+$56.9M
(+14%)
Holding
128
Top Buys
| 1 | +$9.19M | |
| 2 | +$8M | |
| 3 | +$7.87M | |
| 4 |
Vor Biopharma
VOR
|
+$7.64M |
| 5 |
Oric Pharmaceuticals
ORIC
|
+$6.59M |
Top Sells
| 1 | +$19M | |
| 2 | +$18.2M | |
| 3 | +$13.8M | |
| 4 |
Praxis Precision Medicines
PRAX
|
+$10.8M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$9.45M |
Sector Composition
| 1 | Healthcare | 85.98% |
| 2 | Technology | 11.47% |
| 3 | Industrials | 1.25% |
| 4 | Communication Services | 0% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Teva Pharmaceuticals
TEVA
$39.4B
| $35.1M | 7.33% |
1,123,525
-383,500
|
|
||
2
Biogen
BIIB
$28.2B
| $16.7M | 3.48% |
94,738
+12,000
|
|
||
3
Mineralys Therapeutics
MLYS
$2.32B
| $16.3M | 3.41% |
449,003
+229,093
|
|
||
4
Syndax Pharmaceuticals
SNDX
$1.89B
| $16M | 3.35% |
762,563
+374,847
|
|
||
5
Nova
NVMI
$13.9B
| $15.7M | 3.28% |
47,846
+3,950
|
|
||
6
Tower Semiconductor
TSEM
$14B
| $14.4M | 3.01% |
122,513
-189,289
|
|
||
7
Cogent Biosciences
COGT
$6.31B
| $13.4M | 2.81% |
378,500
+279,974
|
|
||
8
AstraZeneca
AZN
$323B
| $12.4M | 2.59% |
135,060
|
|
||
9
Sanofi
SNY
$118B
| $11.6M | 2.43% |
239,515
+20,000
|
|
||
10
Eli Lilly
LLY
$992B
| $9.72M | 2.03% |
9,040
-1,000
|
|
||
11
Amicus Therapeutics
FOLD
$4.51B
| $9.38M | 1.96% |
658,377
-332,765
|
|
||
12
Immatics
IMTX
$1.39B
| $9.04M | 1.89% |
861,105
+278,000
|
|
||
13
BioMarin Pharmaceuticals
BMRN
$11.9B
| $8.74M | 1.83% |
+147,000
|
|
||
14
BridgeBio Pharma
BBIO
$12.9B
| $8.24M | 1.72% |
107,746
+67,000
|
|
||
|
15
Oric Pharmaceuticals
ORIC
$1.31B
| $8.22M | 1.72% |
1,004,378
+572,685
|
|
||
16
Dyne Therapeutics
DYN
$2.57B
| $7.69M | 1.61% |
392,894
-33,624
|
|
||
17
Trevi Therapeutics
TRVI
$1.53B
| $7.49M | 1.57% |
598,534
-45,423
|
|
||
18
Johnson & Johnson
JNJ
$599B
| $7.42M | 1.55% |
35,831
-5,000
|
|
||
19
Savara
SVRA
$1.22B
| $7.1M | 1.48% |
1,178,164
-172,169
|
|
||
20
Scholar Rock
SRRK
$4.52B
| $6.97M | 1.46% |
+158,265
|
|
||
21
Wave Life Sciences
WVE
$2.59B
| $6.94M | 1.45% |
408,166
+358,166
|
|
||
22
Ultragenyx Pharmaceutical
RARE
$2.26B
| $6.91M | 1.44% |
300,623
-51,935
|
|
||
|
HELP
23
Cybin Inc
HELP
$367M
| $6.75M | 1.41% |
825,576
+455,200
|
|
||
24
Annexon
ANNX
$835M
| $6.61M | 1.38% |
1,316,212
-478,175
|
|
||
25
BioCryst Pharmaceuticals
BCRX
$2.17B
| $6.54M | 1.37% |
+837,889
|
|